INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $381,000 | +162.8% | 41,100 | +151.3% | 0.09% | +131.6% |
Q4 2020 | $145,000 | -92.7% | 16,354 | -90.4% | 0.04% | -92.2% |
Q3 2020 | $1,986,000 | +425.4% | 171,200 | +237.0% | 0.48% | +491.5% |
Q1 2020 | $378,000 | +285.7% | 50,799 | +379.2% | 0.08% | +39.0% |
Q2 2016 | $98,000 | – | 10,600 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |